Daniel Muñoz, MD, MPA, associate professor of Medicine, and Francis Miller, MD, professor of Medicine, have been named interim directors of the Division of Cardiovascular Medicine at Vanderbilt University Medical Center.

Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure.

Keith Obstein, MD, MPH, has received the inaugural Innovator of the Year Award from the Brock Family Center for Applied Innovation in recognition of his achievements in developing and commercializing a magnetic, flexible colonoscopy system with the potential to provide a safer alternative to standard colonoscopy.

An undergraduate artist worked with the Vanderbilt researchers to create this oil painting, inspired the research. They are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients.

Kimryn Rathmell, MD, PhD, MMHC, the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), has been named director of the National Cancer Institute

Vanderbilt researchers found that an H. pylori enzyme is essential for colonization of the stomach, suggesting it as a promising therapeutic target for H. pylori infection.

Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers.